References
- Brooks J. The oxidation of haemoglobin to methaemoglobin by oxygen II—The relation between the rate of oxidation and the partial pressure of oxygen. Proc. R. Soc. Lond. 1935; 547: 560–577
- Carmichael F. J., Ali A. C., Campbel J. A., Langlois S. F., Biro G. P., Willan A. R., Pierce C. H., Greenburg A. G. A phase I study of oxidized raffinose cross‐linked human hemoglobin. Crit. Care Med. 2000; 28: 2283–2292
- Caron A., Menu P., Faivre‐Fiorina B., Labrude P., Alayash A., Vigneron C. Systemic and renal hemodynamics after moderate hemodilution with HbOCs in anesthetized rabbits. Am. J. Physiol. Heart Circ. Physiol. 2000; 278: H1974–H1983
- Cohn S. M. Oxygen therapeutics in trauma and surgery. J. Trauma 2002, in press
- Faivre B., Menu P., Labrude P., Vigneron C. Do the dissociation of the dex‐BTC‐Hb and its oxidation influence the P50 in vivo in guinea pig?. Art. Cells Blood Substit. Immobil. Biotechnol. 1994; 22: A97
- Guidiotti G. Studies on the chemistry of hemoglobin. J. Biol. Chem. 1967; 242: 3685–3693
- Lee R., Neya K., Svizzero T. A., Vlahakes G. J. Limitations of the efficacy of hemoglobin‐based oxygen‐carrying solutions. J. Appl. Physiol. 1995; 79(1)236–242
- McGown E. L., Lyons M., Zegna A. Reduction of extracellular methemoglobin by erythrocytes. Biochim. Biophys. Acta 1990; 1036: 202–206
- Neya K., Lee R., Vlahakes G. J. Hemoglobin based oxygen carrying solution stability in extracorporeal circulation: an in vitro evaluation and implications for clinical use. ASAIO J. 1998; 44(3)166–170
- Ning J., Er S. S., Wong L. T. In vivo oxygenation of deoxy‐HEMOLINK™ following exchange transfusions of 50% or 90% the blood volume in rats. Blood Substitutes—Present and Future Perspectives, E. Tsuchida. Elsevier Science, New York 1998; 211–223
- Scott E. M., Duncan I. W., Ekstrand V. The reduced pyridine nucleotide dehydrogenases of human erythrocytes. J. Biol. Chem. 1965; 240: 481–485
- Sprung J., Kindscher J., Wahr J. A., Levy J. H., Monk T. G., Moritz M. W., O'Hara P. J. The use of bovine hemoglobin glutamer‐250 (Hemopure®) in surgical patients: results of a multicenter, randomized, single‐blinded trial. Anesth. Analg. 2002; 94: 799–808